These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34164687)

  • 1. Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016-20.
    Räisänen K; Sarvikivi E; Arifulla D; Pietikäinen R; Forsblom-Helander B; Tarkka E; Anttila VJ; Grönroos JO; Rintala E; Kauranen J; Ahlsved M; Broas M; Mikkola J; Sieberns J; Jalava J; Lyytikäinen O
    J Antimicrob Chemother; 2021 Sep; 76(10):2697-2701. PubMed ID: 34164687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012-2018.
    Räisänen K; Lyytikäinen O; Kauranen J; Tarkka E; Forsblom-Helander B; Grönroos JO; Vuento R; Arifulla D; Sarvikivi E; Toura S; Jalava J
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1651-1656. PubMed ID: 32307627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracing local and regional clusters of carbapenemase-producing
    van Beek J; Räisänen K; Broas M; Kauranen J; Kähkölä A; Laine J; Mustonen E; Nurkkala T; Puhto T; Sinkkonen J; Torvinen S; Vornanen T; Vuento R; Jalava J; Lyytikäinen O
    Euro Surveill; 2019 Sep; 24(38):. PubMed ID: 31552821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sanitary installations and wastewater plumbing as reservoir for the long-term circulation and transmission of carbapenemase producing Citrobacter freundii clones in a hospital setting.
    Hamerlinck H; Aerssens A; Boelens J; Dehaene A; McMahon M; Messiaen AS; Vandendriessche S; Velghe A; Leroux-Roels I; Verhasselt B
    Antimicrob Resist Infect Control; 2023 Jun; 12(1):58. PubMed ID: 37337245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012.
    Gaibani P; Ambretti S; Farruggia P; Bua G; Berlingeri A; Tamburini MV; Cordovana M; Guerra L; Mazzetti M; Roncarati G; Tenace C; Moro ML; Gagliotti C; Landini MP; Sambri V
    Int J Infect Dis; 2013 Sep; 17(9):e714-7. PubMed ID: 23528638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of
    Lalaoui R; Djukovic A; Bakour S; Hadjadj L; Sanz J; Salavert M; López-Hontangas JL; Sanz MA; Ubeda C; Rolain JM
    Antimicrob Resist Infect Control; 2019; 8():167. PubMed ID: 31687131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2.
    Arana DM; Ortega A; González-Barberá E; Lara N; Bautista V; Gómez-Ruíz D; Sáez D; Fernández-Romero S; Aracil B; Pérez-Vázquez M; Campos J; Oteo J;
    J Antimicrob Chemother; 2017 Dec; 72(12):3283-3287. PubMed ID: 29029114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mobile genetic elements carrying VIM-1 and KPC-2 carbapenemases in Citrobacter freundii isolates in Madrid.
    Villa J; Arana DM; Viedma E; Perez-Montarelo D; Chaves F
    Int J Med Microbiol; 2017 Sep; 307(6):340-345. PubMed ID: 28711315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic epidemiology of nosocomial carbapenemase-producing
    Heljanko V; Johansson V; Räisänen K; Anttila VJ; Lyytikäinen O; Jalava J; Weijo I; Lehtinen JM; Lehto KM; Lipponen A; Oikarinen S; Pitkänen T; Heikinheimo A;
    Front Microbiol; 2023; 14():1165751. PubMed ID: 37303777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of carbapenemase-producing
    Hopkins KL; Ellaby N; Ellington MJ; Doumith M; Mustafa N; Meunier D; Woodford N
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35604946
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11).
    Österblad M; Kirveskari J; Hakanen AJ; Tissari P; Vaara M; Jalava J
    J Antimicrob Chemother; 2012 Dec; 67(12):2860-4. PubMed ID: 22855858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of MALDI-TOF mass spectrometry to detect nosocomial outbreaks of Serratia marcescens and Citrobacter freundii.
    Rödel J; Mellmann A; Stein C; Alexi M; Kipp F; Edel B; Dawczynski K; Brandt C; Seidel L; Pfister W; Löffler B; Straube E
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):581-591. PubMed ID: 30680577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of WGS data for investigation of a long-term NDM-1-producing Citrobacter freundii outbreak and secondary in vivo spread of blaNDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Hammerum AM; Hansen F; Nielsen HL; Jakobsen L; Stegger M; Andersen PS; Jensen P; Nielsen TK; Hansen LH; Hasman H; Fuglsang-Damgaard D
    J Antimicrob Chemother; 2016 Nov; 71(11):3117-3124. PubMed ID: 27494919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulation of
    Venditti C; Fortini D; Villa L; Vulcano A; D'Arezzo S; Capone A; Petrosillo N; Nisii C; Carattoli A; Di Caro A
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
    Eda R; Nakamura M; Takayama Y; Maehana S; Nakano R; Yano H; Kitasato H
    J Infect Chemother; 2020 Jul; 26(7):667-671. PubMed ID: 32222331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FosA3 emerging in clinical carbapenemase-producing
    Mattioni Marchetti V; Venturelli I; Cassetti T; Meschiari M; Migliavacca R; Bitar I
    Front Cell Infect Microbiol; 2024; 14():1447933. PubMed ID: 39247055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of possible clonal transmission of carbapenemase-producing Klebsiella pneumoniae complex member isolates in Denmark using core genome MLST and National Patient Registry Data.
    Hammerum AM; Lauridsen CAS; Blem SL; Roer L; Hansen F; Henius AE; Holzknecht BJ; Søes L; Andersen LP; Røder BL; Justesen US; Østergaard C; Søndergaard T; Dzajic E; Wang M; Fulgsang-Damgaard D; Møller KL; Porsbo LJ; Hasman H
    Int J Antimicrob Agents; 2020 May; 55(5):105931. PubMed ID: 32135203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic discrepancies for carbapenemase-producing Citrobacter freundii in multiple isolates from a single patient.
    Brecher SM; Tickler IA; Tenover FC
    Ann Clin Microbiol Antimicrob; 2023 Apr; 22(1):24. PubMed ID: 37055768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.